Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
about
Maternal diet modulates placenta growth and gene expression in a mouse model of diabetic pregnancyTissue Specific Promoters in Colorectal CancermiR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.Effect of 15-hydroxyprostaglandin dehydrogenase gene on the proliferation of gastric cancer cell murine forestomach carcinoma.15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.Prostaglandin catabolic enzymes as tumor suppressors.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.Prognostic implication of 15-hydroxyprostaglandin dehydrogenase down-regulation in patients with colorectal cancer.Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.Herbal formula SC-E1 suppresses lipopolysaccharide-stimulated inflammatory responses through activation of Nrf2/HO-1 signaling pathway in RAW 264.7 macrophagesIntegrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect.
P2860
Q21560980-69EA2948-7B8E-423D-B81A-35595F465E91Q26773374-8014F975-37FB-4419-8C29-64A60A5DDBFBQ33758343-66D0C0D5-8CF5-40B4-B5ED-4EBA672EA1E0Q35077655-8875F02F-0F67-41F5-9AFF-CA84AA541413Q37000533-D595E1F0-7818-40DD-BC0B-E98B97339077Q37388136-0D8CC397-13F3-45BC-AF7E-E1A2519F7DAAQ37549404-FBD3D864-D7BB-433C-A8B3-C7F005778755Q37948688-8C0242AE-BBD7-4120-A243-D721992778BFQ37963769-3C9131A9-36CE-4A6A-BEA1-00D6C04374B1Q38456118-0D233514-B0FD-400E-804E-8735B2AD3EBCQ39198882-700AADBA-FF75-46F6-994D-EB7AECC80586Q42206114-25142BDB-C67C-4BAA-BC18-020DD3BC9A77Q47630528-2C5E2A76-1B75-450F-ADF2-0B2CFF4E86DBQ55239952-0DD11F53-0424-4B17-A062-F822FC11E468
P2860
Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@en
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@nl
type
label
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@en
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@nl
prefLabel
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@en
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@nl
P2093
P1476
Experimental cancer therapy us ...... ndin dehydrogenase expression.
@en
P2093
Cecil R Stockard
Donald J Buchsbaum
Lyudmila N Kaliberova
Sergei A Kusmartsev
Sergey A Kaliberov
Valentina Krendelchtchikova
William E Grizzle
P304
P356
10.1158/1535-7163.MCT-09-0270
P577
2009-11-03T00:00:00Z